{"filings":[{"id":98374,"accession_number":"0000070318-26-000023","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q1 GAAP EPS $8.01, adj EPS $4.82 beats; Ambulatory EBITDA up 6.1%","event_type":"earnings","confidence":"high","bullets":["Net income available to common shareholders $702M ($8.01 diluted EPS); adjusted diluted EPS $4.82 vs $4.36 YoY.","Consolidated revenue $5,368M (+2.8% YoY); adjusted EBITDA $1,162M (flat) with margin 21.6%.","Ambulatory segment adjusted EBITDA $484M (+6.1% YoY); same-facility revenues up 5.3%.","Hospital segment adjusted EBITDA $678M (-4.1% YoY); same-hospital revenues flat due to payer mix.","FY2026 adj EBITDA outlook reaffirmed $4.485B-$4.785B; repurchased 1.35M shares for $318M."],"consensus_eps_estimate":null,"consensus_eps_actual":8.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":5368000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98373,"accession_number":"0000070318-26-000019","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-04-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Tenet Healthcare CIO Paola Arbour to retire Dec 31, 2026; part-time transition through April 2028","event_type":"leadership","confidence":"high","bullets":["EVP and CIO Arbour retires from executive role Dec 31, 2026, stays part-time as non-executive through April 1, 2028 at $820/week.","She remains eligible for 2026 AIP bonus but not 2027; outstanding equity awards continue vesting.","ERA contributions end after 2026; she continues medical benefits and service credit through April 2028.","Agreement includes general release of claims; she will sign supplemental release on last day."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113795,"accession_number":"0000070318-26-000015","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Tenet Healthcare appoints J. Michael Grooms as new Controller, Principal Accounting Officer","event_type":"leadership","confidence":"high","bullets":["Retirement date of principal accounting officer R. Scott Ramsey changed to April 30, 2026; Ramsey to stay part-time through March 2028.","J. Michael Grooms appointed SVP & Controller effective April 6, 2026, becoming principal accounting officer on May 1, 2026.","Grooms previously served as SVP, Chief Accounting Officer at Lifepoint Health since 2018.","Grooms receives $475k base salary, 60% target bonus, $500k RSU grant, and $250k sign-on bonus.","Grooms also recommended for 2027 equity award of $350k, split 50/50 service/performance RSUs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113794,"accession_number":"0000070318-26-000007","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-02-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q4 2025 adjusted EPS $4.70, up 36.6% YoY; FY2026 EBITDA guidance $4.485-$4.785B","event_type":"earnings","confidence":"high","bullets":["Q4 net income $371M ($4.22 diluted EPS); adjusted EPS $4.70 vs $3.44 YoY; revenue $5.527B (+9% YoY).","Consolidated Adj EBITDA $1.183B (+12.9%), margin 21.4%; Ambulatory EBITDA $580M (+9.4%), Hospital EBITDA $603M (+16.4%).","FY2026 outlook: Adj EBITDA $4.485-$4.785B, revenue $21.5-$22.3B; free cash flow $2.94-$3.29B.","Announced $1.9B payment from CommonSpirit over 3 years; Conifer stake redemption; recording $1.65B contract termination revenue in 2026.","Repurchased 8.8M shares for $1.386B in FY2025; completed $2.25B debt refinancing in Nov 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":15.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":21310000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113793,"accession_number":"0000070318-26-000003","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Tenet announces $1.9B CommonSpirit deal; 2025 Adj. EBITDA at upper end of guidance","event_type":"m_and_a","confidence":"high","bullets":["CommonSpirit to pay Tenet $1.9B over 3 years; Tenet redeems CommonSpirit's 23.8% Conifer equity for $540M.","Balance sheet: redeemable non-controlling interest and liabilities reduced ~$885M; APIC increased ~$305M.","Preliminary 2025 Adj. EBITDA at upper end of $4.47B-$4.57B range; strong revenue growth and expense management.","Conifer continues to serve CommonSpirit through 2026; Tenet to invest in AI and automation for Conifer.","Full Q4 and FY 2025 results to be reported on February 11, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130203,"accession_number":"0000070318-25-000050","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Stephen H. Rusckowski resigns from Tenet Healthcare board","event_type":"leadership","confidence":"high","bullets":["Stephen H. Rusckowski resigned from the Board effective November 21, 2025.","Board size decreased from 13 to 12 directors.","No reason for resignation or replacement named."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130202,"accession_number":"0001193125-25-286146","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Tenet issues $2.25B in notes to refinance near-term debt maturities","event_type":"debt","confidence":"high","bullets":["Issued $1.5B of 5.500% senior secured first lien notes due 2032 and $750M of 6.000% senior notes due 2033.","Proceeds plus cash on hand to redeem $1.5B of 6.250% notes due 2027 and partially redeem $0.75B of 6.125% notes due 2028.","First lien notes secured; senior notes unsecured; both have change-of-control and optional redemption provisions.","Covenants restrict liens, asset sales, and mergers but not additional debt, dividends, or investments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130201,"accession_number":"0001193125-25-266885","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Tenet enters $1.9B ABL revolving credit facility maturing 2030","event_type":"debt","confidence":"high","bullets":["New $1.9B senior secured revolving credit facility with $200M letter-of-credit sub-facility.","Facility matures Nov 4, 2030, with springing maturity if certain senior notes exceed $2.5B.","Existing $200M LC facility amended to extend maturity from 2027 to Nov 4, 2030.","ABL interest: base rate +0.25%-0.50% or SOFR/EURIBOR +1.25%-1.50% based on average quarterly availability.","JPMorgan Chase is administrative agent; Barclays Bank PLC is LC facility agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130200,"accession_number":"0000070318-25-000048","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tenet Healthcare prices $2.25B notes offering; upsized senior notes to 6.00% due 2033","event_type":"debt","confidence":"high","bullets":["Offering: $1.5B 5.500% first lien notes due 2032 and $0.75B 6.000% senior notes due 2033 (upsized from $0.5B).","Proceeds to redeem all $1.5B of 6.250% second lien notes due 2027 and partially redeem $0.75B of 6.125% senior notes due 2028.","Redemption date Nov 19, 2025; closing of new notes expected Nov 18, 2025.","Notes offered privately to QIBs and non-U.S. persons under Rule 144A/Reg S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130199,"accession_number":"0000070318-25-000043","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q3 adjusted EPS $3.70 beats $2.93 YoY; raises FY2025 EBITDA outlook","event_type":"earnings","confidence":"high","bullets":["Net income $342M ($3.86 diluted); adjusted EPS $3.70, up 26.3% YoY from $2.93.","Consolidated Adjusted EBITDA $1.099B, +12.4% YoY; margin 20.8%.","Same-facility ambulatory revenue +8.3%; hospital segment EBITDA $607M (+12.6%).","FY2025 Adjusted EBITDA guidance raised to $4.47B-$4.57B (midpoint +$50M).","Repurchased 0.6M shares for $93M in Q3; net debt/EBITDA 2.30x."],"consensus_eps_estimate":null,"consensus_eps_actual":11.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":15783000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146765,"accession_number":"0000070318-25-000031","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q2 adjusted EPS $4.02 (+74% YoY); raises FY 2025 EBITDA outlook to $4.40-$4.54B","event_type":"earnings","confidence":"high","bullets":["Q2 2025 net income $288M, $3.14 diluted EPS; adjusted diluted EPS $4.02 vs $2.31 in Q2 2024.","Consolidated Adj. EBITDA $1.121B (+18.6% YoY); margin 21.3%. Ambulatory Care Adj. EBITDA $498M (+11.4%).","Board authorized $1.5B increase to share repurchase program, leaving $1.781B remaining as of July 22.","FY 2025 Adj. EBITDA outlook raised to $4.40-$4.54B (midpoint +$395M vs prior). Free cash flow guide $2.025-$2.275B.","H1 2025 free cash flow $1.385B vs $948M in H1 2024; net debt/Adj. EBITDA 2.45x."],"consensus_eps_estimate":null,"consensus_eps_actual":7.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":10494000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165184,"accession_number":"0000070318-25-000023","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tenet Healthcare promotes Lisa Y. Foo to Chief Operating Officer (newly created role)","event_type":"leadership","confidence":"high","bullets":["Lisa Y. Foo named COO effective May 30, 2025; position is newly created.","Biographical details incorporated by reference from proxy statement filed April 11, 2025.","Foo's promotion signals potential structural realignment of operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165183,"accession_number":"0000070318-25-000020","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-05-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tenet Healthcare shareholders elect all 13 directors, approve say-on-pay","event_type":"other","confidence":"high","bullets":["All 13 director nominees elected with strong support; Saumya Sutaria received 75.1M for, 3.2M against.","Advisory vote on executive compensation passed with 72.9M for (93% of votes cast excluding broker non-votes).","Ratification of Deloitte & Touche as auditor for FY2025 approved with 85.3M for.","Shareholder proposal on maternal health outcomes failed with only 3.8M for, 73.1M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}